BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
27.03
-0.86 (-3.08%)
At close: Nov 17, 2026

SHA:688166 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3431,2241,2831,1801,0171,052
Revenue Growth
13.81%-4.59%8.73%15.94%-3.33%34.00%
Gross Profit
710.22608.23722.04636.61626.38582.34
Operating Income
105.8751.56200.76208.24231.38249.16
Net Income
102.2854.51189.17202.47239.62243.95
Earnings Per Share
0.240.130.450.480.580.60
EPS Growth
62.19%-71.11%-6.25%-17.24%-3.33%46.34%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Income from sale of Products
1,0791,1491,023877.52927.8
Income from Technology
44.4639.2275.884.3967.78
Equity Share Income
66.0760.0461.951.3954.58
Total
1,1901,2481,1611,0131,050

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,349961.06765.351,0491,230337.6
Total Debt
2,5452,3952,2362,2072,022902.42
Net Cash (Debt)
-1,196-1,433-1,470-1,158-791.15-564.82
Net Cash Growth
------
Net Cash Per Share
-2.82-3.42-3.50-2.75-1.91-1.39

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
430.35325.19245.56194.77311.26176.08
Capital Expenditures
-278.11-453.41-257.2-403.76-726.73-909.66
Free Cash Flow
152.24-128.22-11.64-209-415.47-733.59
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.88%49.71%56.30%53.97%61.57%55.33%
Operating Margin
7.88%4.21%15.65%17.66%22.74%23.67%
Pretax Margin
6.05%1.14%12.26%16.00%23.81%24.46%
Profit Margin
7.62%4.46%14.75%17.16%23.55%23.18%
FCF Margin
11.34%-10.48%-0.91%-17.72%-40.84%-69.71%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0160.0160.0960.0960.1140.120
Dividend Per Share Growth
-83.33%-83.33%0%-15.79%-5.00%42.86%
Dividend Yield
0.06%0.03%0.32%0.27%0.51%0.33%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
112.24380.4467.3973.0339.7961.70
Forward PE
-82.4552.9828.0028.0043.06
PS Ratio
9.0416.959.9412.549.3714.30